SAN DIEGO, CA - (ACCESSWIRE - October 30, 2013) - Vical Incorporated (VICL) will host a live webcast to discuss the results of the third quarter 2013, to be held Thursday, October 31, 2013 at 12:00 p.m. Eastern Time.
The event will be broadcast live online at http://www.investorcalendar.com/IC/CEPage.asp?ID=171839.
If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=171839 or http://www.investorcalendar.com/, as well as via the Vical web site (http://www.vical.com/).
About Vical Incorporated
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen; cancer immunotherapeutics, in which the expressed protein is an immune system stimulant; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and address significant unmet medical needs. Additional information on Vical is available at http://www.vical.com/.
SOURCE: ACCESSWIRE